Cell-based biosensors (CBBs) utilize whole cells to detect biologically act
ive agents. Although CBBs have shown success in detecting the presence of b
iological agents, efforts to classify the type of agent based on functional
activity have proven difficult because multiple biochemical pathways can l
ead to the same cellular response. However, a new approach using a genetica
lly-engineered cell-based biosensor (GECBB) described in this paper transla
tes this cross-talk noise into common-mode noise that can be rejected. The
GECBB operates by assaying for an agent's ability to differentially activat
e two populations of cells, wild-type (WT) cells and cells genetically engi
neered to lack a specific receptor, knockout (KO) cells. Any biological age
nt that targets the knocked out receptor will evoke a response in the WT bu
t not in the KO. Thus, the GECBB is exquisitely sensitive to agents that ef
fect the engineered pathway. This approach provides the benefits of an assa
y for specific functional activity while simplifying signal analysis. The G
ECBB implemented was designed to be sensitive to agents that activate the b
eta1-adrenergic receptor (beta1-AR). This was achieved by using mouse cardi
omyocytes in which the Pl-AR had been knocked out. The cellular signal used
in the GECBB was the spontaneous beat rate of the two cardiomyocyte syncit
ia as measured with microelectrode arrays. The GECBB was able to detect the
beta -AR agonist isoproterenol (ISO) at a concentration of 10 muM (P < 0.0
05). (C) 2001 Elsevier Science B.V. All rights reserved.